SAS | The Power to Know
cq5dam.thumbnail.319.319
White Paper

Optimize Your Launch Sequence Strategies

Maximize global revenue from international pharmaceutical product launches

About this paper

Margins for pharmaceutical products – which had already been dropping in the last decade – are being driven down even further by international reference pricing, the practice of using the price of a product in other countries to set or negotiate the reimbursable price of a product in a given country. For pharmaceutical companies, a misstep in setting prices or choosing the launch sequence can be costly, both during the critical launch period and in market.

The SAS® solution for launch revenue optimization enables global pricing teams to proactively simulate and optimize launch timing and pricing decisions based on the predicted effect on global revenue – while accounting for the complex web of international reference pricing and country-specific rules.

About SAS

SAS is the leader in analytics. Through innovative software and services, SAS empowers and inspires customers around the world to transform data into intelligence. SAS gives you THE POWER TO KNOW®.

Czy masz profil SAS? To complete this form automatically Zaloguj się

*
*
*
*
 
*
 
 
  Tak, wyrażam zgodę, aby otrzymywać okazjonalne wiadomości e-mail od SAS Institute Inc. i jej podmiotów powiązanych o produktach i usługach SAS. Rozumiem, że mogę wycofać swoją zgodę w dowolnym momencie, klikając link podany w wiadomościach e-mail.

Dane osobowe będą przetwarzane zgodnie z oświadczeniem o ochronie prywatności firmy SAS.

 
 

Back to Top